This metabolic dysregulation is defined by systemically reduced levels of metabolites such as amino acids and fatty acids, leading to reduced TCA cycle activity and oxidative phosphorylation, which may ultimately be a major contributor to neuropsychiatric symptoms associated with reduced energy, such as fatigue and other cognitive impairments [43, 62]
Wegovy and Ozempic, Tewari cited average weight loss for the Novo Nordisk treatments of 10% to about 11%, and A1 reduction of 1.6 to ~2.2%
"We believe this potential new medicine can deliver even more weight loss than tirzepatide and it could potentially provide additional health benefits," Daniel Skovronsky, Lilly's chief scientific and medical officer, said during an earnings call on Thursday
However, it is essential to continue monitoring as prescribed, particularly during dose escalation, to ensure glucose levels remain within target ranges
For instance, enzyme-inducing AEDs like carbamazepine and phenytoin can accelerate the metabolism of other drugs, whilst some medications can increase or decrease AED blood levels, affecting seizure control
[26] Jastreboff, A